Skip to main content
Log in

SMC says `yes' to five drugs . . .

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Scottish Medicines Consortium. SMC advice: bevacizumab (Avastin); bimatoprost 0.3mg/mL single-dose eye drops (Lumigan UD); infliximab (Remicade); ingenol mebutate gel (Picato); rivaroxaban (Xarelto); sugammadex (Bridion). Internet Document : 11 Mar 2013. Available from: URL: http://www.scottishmedicines.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

SMC says `yes' to five drugs . . .. PharmacoEcon Outcomes News 674, 11 (2013). https://doi.org/10.1007/s40274-013-0262-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0262-4

Navigation